We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Medical device company Biomet has agreed to pay more than $22 million to settle charges by the Securities and Exchange Commission (SEC) as well as parallel criminal charges by the U.S. Department of Justice (DOJ
SciClone and certain of its directors and officers have agreed to settle the consolidated derivative lawsuits that were filed following the company’s announcement that it was being investigated by the Securities and Exchange Commission (SEC) and the Department of Justice (DOJ) for possible FCPA violations
The Securities and Exchange Commission (SEC) announced that it has reached a settlement with London-based medical device company Smith & Nephew PLC to resolve charges that the company violated the Foreign Corrupt Practices Act (FCPA) when its U.S. and German subsidiaries bribed public doctors in Greece for over a decade in order to win business
